-
-
-
-
-
-
-
TuHURA files drug application for blood cancer treatment
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on TuHURA Biosciences (HURA)
-
-
-
-
-
-
-
TuHURA Biosciences (HURA) stock rises following FDA hold lift
-
-
-
-
-
-
-
TuHURA Biosciences, Inc Appoints Craig L. Tendler M.D., Former Vice President, Oncology Clinical Development, Diagnostics, and Global Medical Affairs, Johnson & Johnson Innovative Medicine Research &
-
-
-
-
-
-
-
TuHURA Biosciences (HURA) Outlines Development Pathway for Single Phase 3 Accelerated Approval Registration Trial in First Line Treatment of Advanced or Metastatic Merkel Cell Carcinoma
-
-
-
-
-
409,071 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

